Becker's Healthcare October 21, 2024
Alexandra Murphy

A total of $66.3 billion in outpatient drugs was purchased through the 340B drug pricing program in 2023, according to data from the Health Resources and Services Administration released Oct. 21.

The program allows safety-net providers to obtain discounted medications. Disproportionate share Hospitals accounted for the largest share of purchases, totaling $51.9 million. Other key...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Health System / Hospital, Pharma, Pharma / Biotech, Provider
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article